Dermatology 2013

Notes: Boehncke, Wolf-Henning

Kirby, Brian

eng

Congresses

Research Support, Non-U.S. Gov’t

Canada

2013/08/03 06:00

J Rheumatol. 2013 Aug;40(8):1410-2. doi: 10.3899/jrheum.130451.

URL: http://www.ncbi.nlm.nih.gov/pubmed/23908534

Author Address: Department of Dermatology, Geneva University Hospital, Geneva, Switzerland. wolf-henning.boehncke@hcuge.ch

 

 

Reference Type:  Journal Article

Record Number: 4321Author: Bomm, L., Fracaroli, T. S., Sodre, J. L., Bressan, A. and Gripp, A. C.

Year: 2013

Title: Off-label use of rituximab in dermatology: pemphigus treatment

Journal: An Bras Dermatol

Volume: 88

Issue: 4

Pages: 676-8

Date: Jul-Aug

Short Title: Off-label use of rituximab in dermatology: pemphigus treatment

Alternate Journal: Anais brasileiros de dermatologia

ISSN: 1806-4841 (Electronic)

0365-0596 (Linking)

DOI: 10.1590/abd1806-4841.20131905

PMCID: 3760958

Accession Number: 24068154

Keywords: Adolescent

Adult

Antibodies, Monoclonal, Murine-Derived/*administration & dosage

Dermatologic Agents/*administration & dosage

Drug Administration Schedule

Female

Humans

Immunosuppressive Agents/*administration & dosage

Male

Middle Aged

*Off-Label Use

Pemphigus/*drug therapy

Treatment Outcome

Abstract: Since its approval in 1997 by the FDA (United States Food and Drug Administration), rituximab has been used for certain B-cell lymphomas and treatment-resistant rheumatoid arthritis. Nevertheless, over the past 14 years, many case reports have demonstrated the efficacy of off-label rituximab in several dermatological inflammatory conditions. This study describes two cases of pemphigus vulgaris and two cases of pemphigus foliaceous that were treated with rituximab at 375 mg/m2 once a week for 4 weeks, and that responded well to treatment.

Notes: Bomm, Lislaine

Fracaroli, Taina Scalfoni

Sodre, Joao Luz

Bressan, Aline

Gripp, Alexandre Carlos

eng

Case Reports

Brazil

2013/09/27 06:00

An Bras Dermatol. 2013 Jul-Aug;88(4):676-8. doi: 10.1590/abd1806-4841.20131905.

URL: http://www.ncbi.nlm.nih.gov/pubmed/24068154

Author Address: University Hospital Pedro Ernesto, State University of Rio de Janeiro, Rio de Janeiro(RJ), Brazil.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295